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Abstract 
Introduction: In Ethiopia, MDR-TB is one of public health problems which need great 
emphasis. Time to sputum culture conversion is often used as an early predictive value 
for the final treatment outcome. Despite, guidelines for MDR prepared every time, 
medication providing freely and centers for MDR expanded, studies on time to culture 
conversion is very limited in Ethiopia. This study will give insights to policy makers, 
planners, clinicians and researchers. 
Objective: The aim of this study was to determine time to sputum culture conversion 
and determinants among MDR TB patients in Amhara Regional State public Hospitals. 
Methods: An institution based retrospective follow up study was conducted and 392 
MDR TB patients were included in the study. Data were entered in to EPI info version 
7.0 and transferred to Stata version 14 for further analysis. The proportional hazard 
assumption was checked.  Parametric survival analysis, both univariate and shared 
frailty model were computed. Cox Snell residual was used for goodness of fit and AIC 
for model selection. 
Result: A total of 340(86.7%) patients changed their initial sputum culture during the 
follow up period. The cumulative proportions of surviving on initial regimen were 89% at 
the end of one month, 56% at the end of two month, and 19% at the end of four month. 
Alcohol drinking (AHR=3.79, 95%CI=1.65-8.68), Sputum smear grading +2 (AHR=0.39, 
95%CI 0.19-0.79), smear grading +3 (AHR=0.30, CI=0.14-064), cavitations (AHR=0.36, 
95%CI=0.19-0.68), and consolidation (AHR=0.29, CI=0.13-0.69) were significant and 
independent predictors of time to sputum culture conversion.  
Conclusion and recommendation: In this study time to sputum culture conversion 
was rapid. Alcohol drinking, sputum smear grading, cavitations and consolidation were 
found to be independent predictors of time to sputum culture conversion. Therefore, it is 
recommended to provide special attention to patients who had baseline radiological 
finding, high bacillary load and those who had history of alcohol intake at the baseline. 
Key words: Time, MDR, culture conversion, Parametric, Survival analysis, Frailty 
model, Amhara Region, Ethiopia 
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1. Introduction 
1.1 Statement of problem 
Globally, tuberculosis (TB) is the second leading cause of morbidity next to human 
immune deficiency virus (HIV), and kills approximately 2 million people per year(1). 
Multi drug resistance (MDR) TB is an increasing global problem (2).About480,000 new 
cases of MDR TB were estimated in 2014. Of this only 136,000 cases were officially 
diagnosed, 48% complete treatment, and 9% were develop extensively drug resistant 
(XDR) tuberculosis(3, 4). The impact of TB is worsen in Asia and Africa(5).About 88% of 
the anticipated MDR-TB cases found in Brazil, China, India, the Russian Federation and 
South Africa(4). According to 2014 global report 28% of MDR TB patients were found in 
the African Region (6), and Ethiopia  ranked 15th among the 27 high MDR-TB burden 
countries; with more than 5000 estimated MDR-TB patients each year. The prevalence 
is 2.8% and 21%  in newly diagnosed patients and in retreatment patients respectively 
(7). Since, the risk is high among previously treated patients, proper treatment and 
enhancing case detection is needed to ensure good success rate and halt the 
emergence of MDR/XDR TB (8). 
Treatment of MDR TB takes 2 years (18-24 months) and monthly sputum culture is 
considered as a remarkable indicator of treatment effectiveness, especially during the 
intensive phase of treatment (9).Culture conversion on MDR TB patient is considered a 
reliable indicator of non-infectiousness and defined as two consecutive negative sputum 
cultures taken at least 30 days apart following an initial positive culture(10). 
In a recent review including 22 studies, the proportion with culture conversion ranged 
from 52% to 95% (the majority were <80%), the median or mean time to culture 
conversion ranged from 35 days to 5 months, and the majority of patients’ sputum 
cultures converted within 2 months (11). Knowing time to Sputum culture conversion is 
often used as an early predictive value for the final treatment outcome, especially in 
MDR TB patients (12). 
The most common Factors that affect time to sputum culture conversion are: MDR 
category, HIV co-infection, presence of radiological finding, presence of chronic 
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disease, number of resistant drugs at the initiation, number of active drugs taken, and 
therapy delay greater than one month(13-16). 
Delaying sputum culture conversion is resulted in economic wastage by prolonging the 
duration of treatment, poor treatment adherence and consequently treatment failure. It 
is also associated with higher case fatality rates (50 - 80%) as a result of drug toxicity 
leading to the emergence of XDR-TB(16). 
The Ethiopian government applied Administrative, environmental, personal respiratory 
protection measures (N95 especially in all MDR centers for patients and health 
professionals), expansion of MDR centers and DOTs strategy to minimize the high 
burden of MDR tuberculosis. However, the prevalence of MDR-TB in Ethiopia is not 
decreasing as expected (7). 
 Despite, provision of free treatment, monthly culture monitoring, and expansion of 
services, studies on time to sputum culture conversion in our country including the study 
area is very limited. Therefore, this study aimed to determine time to sputum culture 
conversion and its predictors among MDR patients.  
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1.2. Literature review 
1.2.1. Time to sputum culture conversation 
Culture positive MDR patients once they initiated on Drug resistance TB treatment; 
there culture is expected to be negative at one point in time in order to have a good 
treatment outcome. Early conversion is a supreme important in the final treatment 
outcome and a patient may cure, treatment completed, die, lost to follow up(LTFU), 
develop treatment failure or he or she may transferred to another facility or they might 
alive in chronic complication.  
Different studies assessed rate of culture conversion among MDR TB patient in different 
way with respect to Socio-demographic, behavioral and Clinical characteristics. A multi 
centered retrospective follow up study conducted in Russia, Peru, Latvia, Estonia, and 
Philippines showed that 85.4% of patients were converted their culture within two to five 
months. The median conversion time was 3.0 months (11). According to a study 
conducted in Latvia 77% of MDR Tb patients were culture negative at the end of 2 
months. The median initial sputum culture conversion time was 83 days(17). One study 
conducted in Pakistan among MDR TB patients showed that the median culture 
conversion time was 196 days with cumulative probability of 6%,33%,47%,and 73% at 
2,4,6, and 8 months respectively (18). A retrospective follow up study conducted in India 
revealed that 83%were become culture negative.  The median time to initial sputum 
culture conversion was 91.3 days. Among these 57%, 73%, and 79% become culture 
negative at the 3, 4, and 6 month respectively (19).  
A prospective study conducted in Georgia showed that 70.7% had culture conversion 
and the median conversion time was 68 days. According to a study conducted in Peru 
the overall culture conversion rate were 87.7% and the median initial culture conversion 
time was 59 days. Of these, 92.5% had culture conversion within 6 month (20). 
According to World health organization  2014 report African Region accounts 28% of 
the world MDR burden and relatively it was the sever form. South Africa alone accounts 
87% of MDR burden in the Africa region(21). 
4 
 
A study conducted in South Africa revealed that 88% of participants were converting 
their culture within the first six month. The overall median conversion time was 62 days 
(22). 
Ethiopia is one of the high burden TB countries with expected incidence rate of 
261/100,000, mortality rate of 35/100,000 and ranked 15 among 27 high burden MDR 
TB cases (23).However, there is no study done on time to sputum culture conversion 
and associated factors in Ethiopia. 
1.2.2. Factors affecting sputum culture conversion time 
Time to sputum culture conversion among MDR patients were vary within individuals. 
This variation mainly affected by the socio demographic, behavioral, and clinical factors. 
Socio demographic factors 
Sex of MDR TB patient is an important predictor for time to initial sputum culture 
conversion. In the study conducted in Indonesia revealed that being female was 
associated with longer duration of culture conversion time. However, a study done in 
Turkey among MDR TB patients revealed that being male has an effect in prolonging 
initial time of culture conversion (24).Age of the respondent had also an effect in MDR 
TB culture conversion time. According to this study old age had a significant effect in 
time to sputum culture conversion (24). 
Behavioral factors 
Behavioral factors like drinking alcohol, smoking and chat chewing are among the 
common behavioral factors affecting sputum culture conversion time. As studies 
showed that currently smoker MDR TB patients had better conversion time as 
compared with nonsmoker, but there is no difference in overall treatment impact (25). 
However, another study in Pakistan and Georgia indicated MDR TB patients who were 
smoker had longer time to sputum culture conversion as compared with nonsmokers 
(18, 26).  
A multi-center study conducted in five world countries by communicable and diseases 
control (CDC), America showed that alcoholic MDR TB patients were significantly 
associated with less conversion rate (delayed conversion time) (11). 
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Clinical factors 
Different studies revealed that severely underweight patients whose Body Mass Index 
(BMI)<16 kg/m(2) had longer initial conversion time as compared with MDR TB patients 
with normal BMI and the probability of conversion within 4 month is low (18, 19, 27). 
Similarly, MDR TB patients with BMI less than 18.5 kg/m(2) resulted in prolonging the 3 
month sputum culture conversion as compared with patients with normal BMI(28). In 
MDR TB patient’s variety of co morbid conditions like Diabetic Mellitus (DM), HIV, and 
anemia affect the conversion time and usually associated with prolonging of culture 
conversion time. Patients with HIV infection or DM had marginally better conversion rate 
than pulmonary tuberculosis patients without any co-morbidity (8).  
Whereas, in a study conducted in Georgia MDR TB patients with DM had longer time 
for sputum culture conversion as compared with non-diabetic patients (26). However, 
another study in Georgia showed that the rate of culture conversion is similar among 
MDR TB patients with DM and without DM (25). A multi-center study conducted in five 
world countries by CDC America revealed that MDR TB patients having previous history 
of TB treatment were statically significant to time of culture conversion and resulted in 
prolonging conversion time (11). 
Different studies revealed that base line radiological findings like consolidation, 
cavitations, infiltration, and pleural effusion had an effect on MDR TB treatment 
outcome and prolonging the time to sputum culture. A study done in South Africa 
showed that presence of lung cavitations or infiltration at baseline on chest X-ray had 
significant effect in prolonging sputum conversion time among MDR patients (29-31).  
Another study conducted in republic of Korea revealed that having MDR and XDR was 
significantly associated with longer duration of culture conversion time as compared 
with drug susceptible patients and other drug resistant (not both Rifampin and 
Isoniazid). This means patients having large number of inactive drugs is significantly 
associated with prolonging the duration of culture conversion and negatively affect the 
treatment outcome. (32). 
Baseline sputum smear grading is an important predictor to time to sputum culture 
conversion as study done in Indonesia showed. According to this study MDR TB 
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patients with high bacillary load (+2 or +3) were resulted in delayed sputum culture 
conversion (33), Latvia (17) and Korea (34). 
Generally, initial times to culture conversion among MDR TB patients were vary from 
patient to patient. This variation was contributed by different socio demographic, 
behavioral, and clinical factors. Majority of the studies were done in Asia, Europe and 
America. In Africa (31)only few studies were done and many of these studies used 
simple binary end point to identify determinants of initial culture conversion time. 
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Figure 1 Conceptual framework of variables that have effect on time to sputum culture 
conversion (adopted from review of literatures) (9, 13, 26, 27, 30, and 33) 
 
 
Socio-demographic factors 
✓ Sex,  
✓ Age,  
✓ Residence, 
✓ educational status, 
✓ Occupation 
 
 
Behavioral factors 
✓ Smoking 
✓ Alcohol drinking 
 
 
Clinical Factors 
✓ HIV co-infection 
✓ MDR category  
✓ Type of resistance 
✓ MDR TB treatment regimen 
✓ Functional status at 1st admission 
✓ presence of chronic disease 
✓ clinical complication 
✓ radiological findings  
✓ therapeutic delay > 1 month 
✓ Number of bacillary load 
✓ Base line BMI 
 
 
 
 
Time to 
conversion 
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Justification of the study 
The treatment of MDR-TB in Ethiopia started recently. Sputum culture conversion is a 
useful and appropriate interim indicator of treatment outcome in patients with multidrug-
resistant TB. Multi drug resistantTB patients with rapid sputum culture conversion are a 
good indicator of good prognosis and minimize the communicability period.  This further 
minimizes the overall burden of the disease. However, there is limited evidences on 
time to sputum culture conversion and associated factors in Ethiopia including the study 
area. 
 
In this study, unobserved heterogeneity were considered for best estimation using frailty 
survival analysis. Studies on some important factors like educational status and 
residency were not addressed in the previous studies.  
 
Similarly, this study will be crucial to policy makers, clinicians, and even for researchers 
as a base line. Hence, the objective of this study is to assess time to sputum culture 
conversion among a cohort of MDR-TB cases and to assess risk factors influencing 
their conversion time. 
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2. Objectives 
2.1. General objective:  
➢ To determine time to sputum culture conversion and determinants among MDR 
TB patients in Amhara Regional State Public Hospitals, Ethiopia. 
2.2 Specific objectives 
➢ To determine time to sputum culture conversion among MDR TB patients in 
Amhara National Regional State 
➢ To identify determinants of sputum culture conversion among MDR TB patients  
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3. Methods 
3.1. Study design and period 
Institutional based retrospective follow up study was conducted from September 2010 to 
December 2016 among MDR TB patients in Amhara Regional State Public Hospitals. 
3.2. Study setting 
University of Gondar referral hospital, Borumeda hospital and Debre-Markos referral 
hospitals were selected among the nine hospitals in the region, which provide MDR 
treatment service, as about 70% of patients enrolled at treatment initiating centers 
(TIC).  
University of Gondar referral hospital is the second hospital Next to St. Peter Hospital; 
which started MDR TB treatment in September 2010 as pilot program with Global 
Health Commute (GHC) approval to treat patients for the national response to the 
emerging threat of drug resistance TB.  
University of Gondar referral hospital is located in North Gondar administrative zone, 
Amhara National Regional state, which is far from about 750 km Northwest of Addis 
Ababa (the capital city of Ethiopia). According to the 2015 population projection for 
major cities in Ethiopia, the total population size of Gondar town was estimated to be 
323,900. Currently Gondar town has one Referral Hospital (UOGRH), eight Health 
Centers, and fourteen health posts which is government owned; there is also one 
general Hospital, thirteen specialty clinics, fifteen medium clinics, and ten primary clinics 
run by private sectors. University of Gondar hospital is a teaching Hospital which serves 
more than five million people of the North Gondar zone, peoples of the neighboring 
zones and some part of Tigray region. It gives service for 313 MDR patients starting 
with the inauguration. 
The second setting is Debre-Markos Referral Hospital which is located in Debre Markos 
town (a capital of east gojjam). It is 297 km far from Addis Ababa and 264 km away 
from Bahirdar, which is the capital of the region. Besides to other services MDR center 
is established in the town recently and has given service for 50 MDR patients. 
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The third setting is Borumeda, which is located 10 km far from Dessie, which is the 
capital of south wello and 441 km far from Addis Ababa. Its center was established in 
2013 and it has given service for 131 MDR patients. 
3.3. Source and study population 
All pulmonary MDR TB patients who were following their treatment in Amhara National 
Regional State hospitals were considered as a source population. Whereas, all 
pulmonary MDR TB patients who were culture positive at the initiation of treatment in 
the three selected hospitals were considered as a study population. 
3.4. Inclusion and Exclusion criteria  
Inclusion criteria: All Drug resistance TB patients who were culture positive at the start 
of treatment at least for two month and have follow up at UOGRH, Debre Markos, and 
Borumeda hospitals from 2010-2016 were included in the study.  
Exclusion criteria: Patients who have incomplete data on the outcome variables were 
excluded. Culture positive MDR patients who were follow less than two months and 
MDR TB patients who were culture negative at the start of the study were also excluded 
in the study. 
3.5. Sample size and sampling procedures 
3.5.1. Sample size determination:  
Initially, University of Gondar referral hospital, Debre Markos hospital, and Borumeda 
hospital were selected. Because these hospitals were the 1st in providing treatment and 
had the largest number of patients and assumed to be representative of the region. 
According to a retrospective follow up study conducted in Pakistan to assess time to 
sputum culture conversion and associated factors being female (CHR=1.93),  current 
smokers (CHR=0.2),prior history of 2nd line drug use (CHR=0.39) and age> 40 years 
(0.48) were used to estimate the sample size (35). 
Estimated sample sizes for two-sample comparison of survivor functions Log-rank test, 
Freedman method is used with the following considerations;  
STATA version 14 is used for sample size determination. 
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Table 1: Sample size comparison using Log-rank test Freedman method 
Outcome  Proportions Withdrawal 
probability 
Power Final 
sample size 
Time to 
conversion 
0.73 at 8 months 5% 80% 358 
Predictors Assumptions Proportion HR Sample size 
Female sex Power=80% 
1:1(ratio), wdprob=5% 
0.73 1.93 228 
Current smoker Power=80% 
0.077(ratio), wdprob=5% 
0.73 0.2 165 
Age>40 years Power=80% 
1:4(ratio), wdprob=5% 
0.73 0.48 146 
Prior 2nd line 
drug 
Power=80% 
1:5(ratio), wdprob=5% 
0.73 0.39 123 
 
According to the sample size calculation, we used the largest of all which is 358. 
Therefore, the total number of sample in this study was 358. However, the total number 
of cases which fulfilled the inclusion criteria was 392.  
 
 
 
 
 
13 
 
3.6. Variables of the study 
3.6.1. Dependent variable  
✓ Time to sputum culture conversion 
3.6.2. Independent variables  
Time to sputum culture conversion is affected by different factors which include socio-
demographic, behavioral and clinical factors which are listed below. 
✓ Socio-demographic characteristics: Sex, age, residence, educational status, 
and marital status 
✓ Behavioral factors: Smoking, alcohol drinking 
✓ Clinical characteristics: HIV co-infection, MDR category, MDR treatment 
regimen, type of resistance, presence of chronic disease, clinical complication, 
radiological findings, therapeutic delay > 1 month, base line BMI, smear grading 
and functional status. 
3.7. Operational Definition 
Time to sputum culture conversion- is a time from the initiation of treatment of MDR 
TB to a patient had 2 negative consecutive cultures taken at least 30 days apart after 
initiation of treatment.  
Censored- when the outcome of interest has not been observed for an individual this 
includes treatment stopped while culture is positive, died before conversion, transfer out 
before conversion and study time completion before culture conversion. 
 
Cohort - Group of patients diagnosed and registered for MDR-TB treatment. 
Therapeutic delay – A confirmed MDR-TB patient who starts treatment after one 
month of MDR TB diagnosis 
Previously not treated for TB  A patient who denies having had any prior anti-TB 
treatment or taking anti TB less than one month. 
Previously treated case - A patient who were treated for TB for one month or more 
BMI–Low BMI: A patient who had under <18.5 kg/m2 body mass index  
Normal BMI: A patient who had ≥18.5kg/m2 body mass index:  
14 
 
Acid Fast Bacilli (AFB): Sputum smear microscopy was performed at baseline and on 
monthly follow-up using Ziehl- Nielsen staining. Results are reported based on the 
number of acid-fast bacilli (AFB): negative (no AFB/ 100 high-power fields [HPF]), 
scanty (1–9 AFB/100 HPF), 1+ (10–99 AFB/100 HPF), 2+ (1–9 AFB/HPF) and 3+ (.>9 
AFB/HPF). 
3.8. Data collection procedures and quality control 
3.8.1. Data collection procedure 
Prior to data collection, the records were reviewed (both baseline and follow up records) 
were identified by their medical registration/card number. Then data collectors were 
reviewed and extract data from patient charts and registries using a semi structured 
check list. Data extraction check list were prepared in English from patient’s card. 
 
3.8.2. Data collectors 
Nine health care professionals (nurse and health officer) collected the data.  Four data 
collectors in Gondar, three for Borumeda and two for Debre Markos were involved in 
data collection. 
3.8.3. Data quality control 
Training on the objective of the study and how to review the documents as per the data 
extraction format were given to data collectors. The PI supervised the overall process. 
The filled formats checked for completeness by the PI and three supervisors.   
3.9. Data processing and Analysis 
The data were entered in to EPI info version 7 and exported to Stata version 14 
statistical software for further analysis. Baseline weight and height which was taken 
from the registration book were used to calculate BMI. Then BMI was computed by 
weight/ (height) 2.  
Descriptive summary statistics like median survival time, Kaplan Meier curve survival 
estimation and Log rank test were computed.  
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Proportional hazard assumption was checked both graphically and hypothesis test 
called Schoenfeld residual test which assessed the relationship between the scaled 
Schoenfeld residuals and time. Schoenfeld residuals test (global test) showed that PHA 
was satisfied. At the same time Schoenfeld residual test was done for all variables and 
all met the proportional hazard assumption. 
After proportional hazard assumption checked; Cox regression model for bivariable and 
multi variable analysis were done. After fitting the Cox regression model AIC and BIC 
were estimated for model comparison. Then, parametric, and frailty models were done 
for time to sputum culture conversion to identify the potential determinants. 
Hazard ratio is used as a measure of the probability of culture conversion, assuming 
that the Survival model is usually expressed in terms of hazard function.  
Once Cox regression model fitted, parametric survival analysis model were fitted by 
considering the baseline hazard with different distribution assumption. Under the 
parametric approach, the baseline hazard is defined as a parametric function and the 
vector of its parameters are estimated together with the regression coefficients and the 
frailty parameter(s). 
i). Baseline Exponential Distribution 
The exponential distribution, with only one unknown parameter and it is the simplest of 
all life distribution models. In the exponential model, the conditional probability is 
constant over time. In other words, the main feature of exponential distribution is that 
the instantaneous hazard does not vary over time. The hazard function under this model 
is to assume that it is constant over time. 
ii). Baseline Weibull Distribution 
Weibull distribution is one of the parametric distributions which are used for the analysis 
of survival data. The Weibull distribution is more general and flexible than the 
exponential distribution and allows for hazard rates that are non-constant but 
monotonic.  
 
Sometimes there may be heterogeneity, due to unobserved covariates added to the 
measurement error of observed covariates.  Thus frailty model takes this into account to 
give a random effect model for time-to-event data, by adding a frailty term, Z. There are 
two types of frailty (Univariate and multivariate (shared frailty) model). Univariate frailty 
16 
 
assumes there is unknown covariates exist across an individual level and shared frailty 
model considers individuals in the same cluster have the same frailty and differ across 
the groups. 
Then both univariate and shared frailty model were tested by considering different 
parametric distribution and frailty distribution (gamma and inverse Gaussian). A more 
parsimonious hazard model was chosen by means of the log likelihood ratio (LR) test 
and Akaike Information Criterion (AIC). Thus in the case of a comparison between 
models, we compared using both log likelihood ratio test and AIC value. The best fitted 
model was chosen using AIC and those having the smallest AIC were considered as a 
best fitted model. Similarly, goodness of model fitness also checked using Cox Snell 
residual test.  
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3.10. Ethical considerations 
Ethical clearance was obtained from Institutional Review Board of University of Gondar. 
Supportive letter was received from Amhara Regional Health Bureau then permission 
letter was obtained from the hospitals administration and the MDRTB focal persons in 
UOGRH, Debre Markos and Borumeda hospital. Name of patients were not included 
during data collection. Questionnaires kept securely in locked cabinets and the data 
base entered into soft-wares was password protected. 
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4. Result 
4.1. Baseline socio demographic characteristics of patients on MDR TB treatment 
About 428 pulmonary MDR patients were reviewed. Among this 36 (8.4%) were 
excluded from the study because of baseline negative culture and contaminated result. 
Thus a total of 392 (91.6%) study units were included in the analysis. The majority of 
patients were attended at University of Gondar referral hospital 242(61.7%) followed by 
Borumeda hospital 113(28.8%), and the remaining were from Debre Markos hospital 
(Figure 2). 
 
 
Figure 2 The Frequency distribution of number of MDR TB patients in Amhara Regional 
State Public Hospitals, September 2010 to December 2016. 
Out of 392 participants, the median age of MDR TB patients at the initiation of MDR TB 
treatment was 29.5 years IQR (20-40 years). One-third of the participants 127 (32.4%) 
were under 25years. More than half of the respondents 228(58.2%) were males and 
about half of the respondents 200(51%) were urban dwellers. About 168(42.9%) were 
private workers and 314 (80.1%) were orthodox Christian’s. Around 40% of MDR TB 
patients were not formally educated and 164 (41.8%) of respondents were married 
(Table 2). 
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Table 2: Baseline socio demographic and behavioural characteristics of MDR TB 
patients at initiation of MDR treatment in Amhara regional State Public Hospitals, Sep 
2010 to December 2016 (n=392). 
Variables Frequency  Percentage  
Age 
<=24 
25-34 
35-44 
>45 
 
127 
126 
73 
66 
 
32.4 
32.2 
18.6 
16.8 
Sex 
Male 
Female 
 
228 
164 
 
58.2 
41.8 
Place of residence 
Urban 
Rural 
 
200 
192 
 
51.0 
49.0 
Occupational status 
Unemployment 
Governmental 
Private 
Daily laborer 
Student 
House wife 
 
89 
36 
168 
37 
40 
22 
 
22.7 
9.2 
42.9 
9.4 
10.2 
5.6 
Religion 
Orthodox 
Muslim 
Other 
 
314 
72 
6 
 
80.1 
18.4 
1.5 
Educational status 
No formally educated 
Grade 1-8 
Grade 9-12 
 
156 
12 
74 
 
39.8 
31.6 
18.9 
20 
 
Variables Frequency  Percentage  
Tertiary and above 38 9.7 
Marital Status 
Married 
Never married 
Divorced 
Widowed 
Separated 
 
164 
135 
50 
8 
35 
 
41.8 
34.4 
12.8 
2.1 
8.9 
Baseline Smoking 
Yes 
No 
 
56 
326 
 
14.3 
85.7 
Baseline Alcohol drinking history 
Yes 
No 
 
77 
312 
 
19.6 
80.4 
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4.2. Baseline clinical status of the study participants 
Among 392 MDR TB patients,9.9% had chronic disease. Of these 12 (3.1%) had DM 
and 4 (1%) had HTN. About one fourth (25.8%) of MDR TB patients had HIV co-
infection .Among HIV positive patients, 95(94.1%) were on ART. Of these, 64.7% MDR 
TB patients were stage III and 33.3% were stage IV at the start of MDR treatment. 
Whereas, no patient were at stage one at the beginning of MDR TB treatment and the 
remaining 2 (2.0%) were start at stage II.  
Majority of MDR TB 272(69.4%) were ambulatory and 376 (95.9%) hospitalized at the 
initiation of treatment. About 11 (2.8 %) of participants had previous MDR TB treatment 
and nearly half 50.8% of participants were mono resistance (Rifampin resistance). 
Regarding on x-ray finding, 107 (27.3%) of MDR TB patients and 160(40.82%) of 
participants had infiltration and cavitations respectively. 
About 286 (73.0%) of participants had low BMI (<18.5kg/m2) and 7 (1.8%) of MDR TB 
patients had treatment modification. Among the 7 MDR TB patients 5 were due to MDR 
TB treatment failure suspect, one patient due to XDR TB confirmed and one due to life 
threatening drug side effect. Regarding with history of previous TB treatment,350 
(89.3%) were previously treated for TB(Table 3). 
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Table 3 Baseline clinical status of MDR TB patients at the initiation of treatment, in 
Amhara Regional State Public Hospitals, September 2010 to December 2016. 
Clinical factors Frequency  Percentage  
HIV co-infection 
Yes 
No 
 
101 
291 
 
25.8 
74.2 
Chronic disease 
Yes 
  No 
 
39 
353 
 
9.9 
90.1 
Functional status 
Working 
Ambulatory 
Bedridden 
 
47 
272 
73 
 
12.0 
69.4 
18.6 
Model of Rx initiation 
Hospitalized 
Ambulatory 
 
376 
16 
 
95.9 
 4.1 
Type of resistance 
Mono resistance 
MDR &XD 
 
199 
193 
 
50.8 
49.2 
BMI 
<18.5 kg/m2 
>=18.5 
 
286 
106 
 
73.0 
27.0 
Rx modified 
Yes 
No 
 
7 
385 
 
1.8 
98.2 
Registration group 
Previously not treated for 
TB 
Previously treated for TB 
 
42 
 
350 
 
 
10.7 
 
89.3 
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Among 392 MDR TB patients 27.3% had baseline infiltration and nearly 41% had 
baseline cavitations (Figure 3) 
 
Figure 3 radiological findings of MDR patients at the baseline in Amhara Regional State 
Public Hospitals, September 2010 to December 2016 
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Among 392 MDR patients,98 (25%) had complication. Of these 41 (41.84%)had 
pneumonia, 24(24.5%) had fibrotic change, 16 (16.3) had COPD, and 9% had 
pneumothorax (Figure 4). 
 
Figure 4 Complication status of MDR TB patients in Amhara Regional State Public 
Hospitals, September 2010 to December 2016 
4.3.3 Diagnosis method and Treatment outcome of MDR TB patients 
Next to cough fever is the most common presentation of MDR TB patients by 366 
(93.4%) and followed by weight loss which accounts 365 (93.1%). Among a total of 392 
MDR TB patients 136 (34.7%) had shortness of breath and around 285 (72%) had chest 
pain. About 319 (81.4%) and 305 (77.8%) of participants had history of fatigability and 
poor appetite. 
Multi Drug Resistant TB patients were diagnosed by different methods. Among 392 
MDR TB patients, 177 (45.2%) were diagnosed by MTB/gene expert, followed by LPA 
139 (35.4%), by culture/DST 64 (16.3%) and clinically 12 (3.1%). 
Among 392 MDR TB patients, 52 (13.3%) were censored and 340 (86.7%) were 
converted their culture.  
The overall cure rate among MDR TB patients were 55.1% and 12 (3.1%) were 
completed (Figure 5) 
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Figure 5 Overall treatment outcome of MDR TB patients in Amhara Regional State 
Public Hospitals, September 2010 to December 2016 
4.4. Time to sputum culture conversion 
Study subjects were followed for different periods which gave a total of 1000.6 person 
months (83.4 person years) observation. Median follows up period was 65 days CI (61-
70). 
The cumulative probability of survival on initial conversion at the end of 1 month were 
0.89, at the end of 2months were 0.56,and at the end of 4 months were 0.19 (Figure 6). 
55%
3%
11%
7%
20%
4%
Cured
Complated
Died
LTUP
On treatment
Other
26 
 
 
Figure 6 Kaplan-Meier curve showing survival of MDR TB patients on initial culture 
conversion in Amhara Regional State Public Hospitals, September 2010 to December 
2016.  
4.5. Predictors of initial sputum culture conversion using Log rank test 
Differences in all key variables at baseline between strata were determined using log 
rank (χ2) test and assessed the equality of hazard for the different explanatory 
variables. According to the test results presence of infiltration (Chi2(16.23) 
=prob>Chi2=0.0001, cavitations (Chi2 (32.2) =prob>Chi2=0.000,consolidation(Chi2 
(6.29) =prob>Chi2=0.0122, Fibrotic change (Chi2 (9.07) =prob>Chi2=0.0026,functional 
status(Chi2 (6.9) =prob>Chi2=0.0318, sputum smear grading(Chi2 (25.01) 
=prob>Chi2=0.0000and resistance type (Chi2 (4.94) =prob>Chi2=0.00263 were 
significantly associated with initial culture conversion time in patients on MDR treatment 
(P-value < 0.05). 
Similarly the plot log-log of survival against log of survival time was done and the study 
indicated roughly parallel graphs for duration of follow up, thus proportional hazard 
assumption was met. There was an interaction between functional status and time 
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indicating possible violation of PH assumption. However, the Schoenfeld global test of 
the functional status satisfies the PH assumption (chi2 (2) = 2.45, Prob>chi2=0.294). 
As the graph shows below mean survival time on culture conversion for patients who 
were bedridden had a median conversion time of 87 days. Whereas, those ambulatory 
and working patients had a median conversion time of 63 and 56 respectively and the 
difference was significant (p-value=0.0318) (Figure 7). 
 
 
Figure 7 Kaplan-Meier curve of surviving MDR TB patients on initial culture conversion 
by baseline functional status in Amhara Regional Public Hospitals, September 2010 to 
December 2016. 
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The survival curve plotted below indicted that the estimated survival curves of hospital 
and the log rank test used for checking the differences in survival curve displayed. 
There was no overall difference between the survival curves of the hospitals as the log 
rank test supported the null hypothesis (log rank Chi-square (2) = 7, p= 0.2294).The 
median culture conversion in Gondar, Borumeda and Debre Markos were 65 CI (61-76), 
63 (53-80) and 62 (42-76) days respectively (Figure 8). 
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Figure 8: Plot of the probability of survival by hospital and the time of follow up (in days) 
among MDR TB patients in Amhara Regional State Public Hospitals, September 2010 
to December 2016 
Model comparison criteria 
Based on Akaike Information Criterion, the univariate frailty with Weibull distribution and 
gamma frailty (AIC=396.82) model was more efficient than Cox-proportional hazard 
(AIC = 1859.41), parametric exponential model (AIC = 545.05) and other frailty models 
(Table 4). Thus, the inclusion of a frailty effect estimated was none statistically 
significant variance and indicates the absence of a heterogeneity or unobserved 
variability among hospitals. But, there is statistically significant heterogeneity among 
individuals (variance=1.56). 
Table 4 Model comparison criteria for the different models using AIC 
Model Baseline 
hazard 
Frailty Variance Log 
likelihood 
AIC 
Cox Unspecified   -919.71 1859.41 
Exponential 
Reg 
Exponential   -261.89 545.05 
Weibull Reg Weibull   -200.99 425.99 
Gompertz 
Reg 
Gompertz   -237.33 498.66 
Univariate 
frailty 
Weibull Gamma 1.56(P<0.001) -185.41 396.82 
Univariate 
frailty 
Weibull Inversegaussian 3.1(P<0.001) -189.53 405.06 
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Goodness of fit test 
Goodness of fit for the fitted model also performed using Cox Snell residual test and 
shows the model was adequate (Figure 9). 
Figure 9 Goodness of fit test for univariate Weibull distribution gamma frailty model 
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Univariate frailty model analysis 
Finding from bivariate analysis showed that alcohol drinking, type of resistance, 
baseline sputum smear grading, cavitations at baseline, baseline infiltration, baseline 
consolidation, chronic fibrotic change at the baseline, and baseline functional status 
were significantly associated with culture conversion time. 
However, in the multi-variable analysis baseline alcohol drinking status, baseline 
sputum smear grading, baseline cavitations, and consolidation were remained statically 
significance predictors of time to sputum culture conversion.  
The rate of sputum culture conversion among those who didn’t drink alcohol at the 
baseline had 3.79 times as compared to alcohol drinkers(AHR=3.79(CI:1.65-8.68)).  
The rate of sputum culture conversion among MDR TB patients whose baseline sputum 
smear grading +2 was decreased by 61%(AHR=0.39(CI: 0.19, 0.79) as compared to 
MDR TB patients whose baseline smear grading +1. Similarly, the rate of culture 
conversion among MDR TB patients whose baseline smear grading +3 was decreased 
by 70% (AHR=0.30(0.14, 0.64)) as compared with those baseline sputum smear +1. 
Regarding on x-ray finding MDR TB patients who had cavitations at the baseline 
decreased culture conversion time by 64% as compared to those MDR TB patients 
without cavitations (AHR=0.36(CI:0.19,0.68)). Similarly, the rate of sputum culture 
conversion among MDR TB patients who had consolidation at the baseline is decreased 
conversion time by 71% as compared to MDR TB patients who had no consolidation 
(AHR=0.29(CI:0.13,0.69)). 
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Table 5 Univariate Weibull distribution gamma frailty model for factors affecting time to 
sputum culture conversion among MDR TB patients in Amhara Region State Public 
Hospitals, September 2010 to December 2016. 
Variable Censored Event CHR 95%CI AHR 95%CI 
Baseline Alcohol history 
Yes 
No 
 
14 
38 
 
63 
277 
 
1 
2.42(1.83,3.21) 
 
1 
3.79(1.65-8.7)* 
Type of resistance 
Mono resistance 
MDR and XDR 
 
34 
18 
 
165 
175 
 
1 
0.72(0.58,0.89) 
 
1 
0.73(0.42,1.28) 
Sputum smear grading 
Smear G-1 
Smear G-2 
Smear G-3 
 
4 
9 
12 
 
114 
53 
44 
 
1 
0.65(0.47,0.89) 
0.37(0.26,0.54) 
 
1 
0.39(0.19,0.79)* 
0.30(0.14,0.64)* 
Cavitations 
No 
Yes 
 
24 
28 
 
208 
132 
 
1 
0.52(0.41,0.64) 
 
1 
0.36(0.19,0.68)* 
Infiltration 
No 
Yes 
 
32 
20 
 
253 
87 
 
1 
0.55(0.43,0.71) 
 
1 
0.76(0.38,1.53) 
Consolidation 
No 
Yes 
 
48 
4 
 
296 
44 
 
1 
0.57(0.42,0.79) 
 
1 
0.29(0.13,0.69)* 
Chronic fibrotic change 
No 
Yes 
 
40 
12 
 
265 
75 
 
1 
0.63(0.48,0.82) 
 
1 
0.54(0.28,1.04) 
Functional status 
Working 
Ambulatory 
Bedridden 
 
8 
23 
21 
 
39 
249 
52 
 
1 
0.8(0.5,1.1) 
0.5(0.4,0.8) 
 
1 
0.75(0.33-1.69) 
0.35(0.12,1.05) 
*indicates p-value <0.05 
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5. Discussion 
In this study the median culture conversion time was 65 days. Having previous history 
of MDR treatment, baseline alcohol drinking status, baseline sputum smear grading, 
radiological findings like cavity and consolidation were found to be determinants of time 
to sputum culture conversion in this study. 
Median culture conversion time in this study was 65 days. This finding is in line with a 
study conducted in South Africa (22) and Georgia(20). However, this finding showed 
delayed conversion as compared with study conducted in Peru (36)with median 
conversion time of 59 days. In Peru (36)these DST results as well as any prior anti-TB 
drug exposure were taken into account when formulating the treatment regimen but in 
our study DST was done after start of treatment with some indication. 
In contrast, our study showed that a rapid culture conversion time as compared with a 
multi centered study conducted in five countries Peru, Latvia, Estonia, Russia, and 
Philippines in which the median culture conversion time was 3 months (90days) and 
similarly, a study in Pakistan had a median conversion time of 191 days(11, 35). This 
might be explained by in defining the outcome variable, since in our study culture 
conversion time is explained by two consecutive negative culture results, whereas, the 
multicenter study defining outcome when five consecutive culture results becomes 
negative. The second possible reason might be a very small sample size used in 
Pakistan study(N=85). The third reason could be in the present study upon positive 
sputum smear microscopy and detection of Rifampicin resistance by MTB/Rif Xpert is 
used to place patients on standardized treatment regimen right from the beginning 
rather than waiting for DST results (35). 
In MDR TB patients alcohol drinking were resulted in delayed culture conversion time. 
This finding is in line with a multi centered study conducted in five countries Peru, 
Estonia, Philip pines, Latvia and Russia (11). This might be explained by large number 
of MDR patients who drink alcohol had cavitations in the multicenter study (11).The 
second reason could be related to poor nutritional status, direct toxic effects of ethanol 
on the immune system or poorer adherence to anti-tuberculosis treatment (37, 38).The 
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third reason might be alcoholism causes drug resistance by decreasing immunity 
status(39). 
Multi drug resistance TB patients whose smear +2 and +3 were statistically significant to 
time to culture conversion and resulted in delayed culture conversion time. This finding 
is in line with a study conducted in Latvia(17), Korea (34) and Indonesia (33).Patients 
with high smear grading had high bacillary load. Having a high bacillary burden 
suggests stronger infectivity and requires a longer isolation period and more intensive 
treatment. Thus, it needs time to clear the bacilli if the bacillary load is high (34). The 
second possible explanation could be the presence of high bacillary load is better 
associated with reduction in bacterial killing and sterilizing activity of anti-TB drugs. It 
may be natural that patients with a higher colony count take a longer time to convert 
sputum cultures. This result suggests the importance of early detection and rapid 
cure(40). 
Multi drug resistance TB patients who had baseline cavitations had statistically 
significant effect on time to culture conversion and resulted in delayed conversion time. 
The negative association between time to sputum culture conversion and lung 
cavitations in our study is in line with studies conducted in China (31) and Pakistan (29). 
The possible reason might be presence of lung cavitations decrease penetration and 
antibacterial activity of drugs (41). In contrast to our finding, studies conducted in South 
Africa have found no significant association between lung cavitations at baseline chest 
X-ray and culture conversion time (30). The possible reason might be explained by a 
larger sample used in our study and the second reason might be proportion of HIV co-
infected in this study were 4 times lower than the study in South Africa (30).  
The presence of consolidation on chest radiography was associated with a longer time 
to initial sputum culture conversion as compared with MDR patients who had no 
baseline consolidation. Consolidation occurs through accumulation of inflammatory 
cellular exudates in the alveoli and adjoining ducts. The liquid can be pulmonary edema, 
inflammatory exudates, pus, inhaled water, or blood (from bronchial tree or hemorrhage 
from a pulmonary artery). This minimizing the response to MDR treatment and may 
delay culture conversion time (42). In contrast to this finding a study conducted in South 
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Africa revealed that there is no significant relationship between baseline consolidation 
and time to sputum culture conversion. This finding might be explained by a small 
sample (n=56) and the second reason could be in South Africa majority (88%) of 
participants were HIV positive and these groups were immune compromised. Since, 
radiological finding in immune compromised persons like HIV may not have sufficient 
lung finding (30). 
Sputum culture conversion in MDR TB patients is an important routine indicator in 
monitoring the treatment outcome. Achieving more rapid sputum culture conversion can 
increase patients comfort by reducing duration of an inject able drug use and simplify a 
patient’s therapy. In addition, from the public health perspective, reducing the time to 
sputum culture conversion is an important infection control measure because patients 
with MDR TB and positive sputum cultures are infectious and may transmit the disease 
to other persons, family members, and health care providers (17). 
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6. Strength and Limitation 
Strengths of the study 
➢ Our study incorporated a multi-center site, 
➢ Implementation of frailty model estimation instead of a binary end point (logistic 
regression) of culture conversion was considered as the strength of this study. 
➢ Handling interval censoring by using parametric survival analysis. 
Limitation of the study 
Since the data were collected from secondary source: some important predictors like 
HGB, BCG scar, and income were missed, which had a significant association with time 
to sputum culture conversion in other studies. 
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7. Conclusion and Recommendation 
7.1. Conclusion 
The time to culture conversion in our study was rapid.  
Having previous alcohol drinking, high baseline sputum smear grading, presence of 
cavitations and consolidation were found to delay time to sputum culture conversion. 
7.2. Recommendation 
To Health care providers 
➢ Close follow-up, attention and health education is important especially those who 
were alcohol drinker. 
➢ It is better to give special attention for patients who have baseline cavitations, 
and consolidation. 
➢ It is better to assess baseline sputum smear grading and provide great attention 
to those who had high bacillary load. 
To MDR-TB wards  
➢ It is better to fill documents and correct miss label charts and registration books 
To researcher  
➢ It is recommendable to conduct prospective follow up study including other 
independent variables (Anaemia, BCG scar, income). 
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Annex 
Annex I Data collection Check list 
This checklist is prepared for the collection of socio-demographic, clinical, behavioral 
factors, and treatment outcome related information that are important for the 
assessment of outcome and predictors of time to sputum culture conversion in 
University of Gondar Hospital, Debre Markos hospital and Borumeda hospital. All these 
information were retrieved from the clients MDR-TB registration book and from 
individual patient card without mentioning the name of clients. This information was 
collected by health care providers (BSc nurse or Health Officer).  
Contact Information Temesgen Yihunie Tel +251-929-390-709 Dr.  Kassahun 
Alemu Tel +251-911-752-466 Mr. Kindie Fentahun Tel:+251928436726 
Part one - Baseline variables   
s.n Variables 
 
Labels  
                                                    . 
1 Patient identification code Unique code------------- 
2 Name of hospitals  1.Gondar-------------- 
2.Borumeda----------- 
3.D/markos------------ 
3 Age of patient in years ______years 
4 Sex 1. Male             2. Female 
5 Address Region----- zone------woreda-------kebele---
- 
6 Place of Residence 1.Urban  2.Rural   
7 Occupation 1. Unemployment   2.Goverment   3.None 
government 4.Private   5. Other-------- 
8 Religion 1. Orthodox   2.muslim 3.Protestant 
4.Catholic 5. Other- 
9 Baseline weight  ___ in Kg  
10 Baseline height -------in centimeter 
11 Educational status 1. No educated 2. Primary 3. Secondary   
4. Tertiary    
12 Marital status 1. Married   2. Never married 3. Divorced   
4. Widowed   5. Other------ 
13  Baseline smoking  1. Yes 2. No 
14 Baseline alcohol drinking  1. Yes 2. No 
15 Presence of other chronic diseases 1. Yes      2. No     3. Unknown  
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16 If yes for Q 15then what are? 1. DM   2.HTN 3. CKD 4.Bronchial asthma 
5. Other(specify) 
17 Registration group 1. New 2. Relapse 3. After LTFP 4. After 
failure of first line treatment 5. After failure 
of retreatment 6. Other 
18 Model of treatment initiation 1. Hospitalized 2. Ambulatory 
19 Date of MDR-TB Diagnosis dd/mm/yy ----/------/------ 
20 Date of MDR-TB treatment started dd/mm/yy ----/------/------ 
21 Time of sputum culture converted  dd/mm/yy----/----/---- 
22 functional status at first admission  1. Working 2. Ambulatory 3. Bedridden 
23 Type of resistance  1.mono resistance 2.poly resistance 
3.MDR 4.XDR 
24 To which anti TB drug patients 
resistance  
1.R only  2.R& H 3.R,H,E,S 
25 Laboratory Diagnosis confirmed by 1.MTB/RIF gene Xpert  2.LPA 
3.conventionl DST 
 
26 Any TB related complication 1. Yes 2. No 
27 If yes to Q.25 type of complication 1. Pneumothorax 2. Pneumonia 3. 
Hemoptysis 4. Cor pulmonale  
1. Other----------- 
28 HIV co-infection 1. No       2. Yes 3. Didn’t test 4. Unknown 
29 If yes for Q.28 CD4 cell count, at 
the beginning of MDR-TB treatment 
------- count of cells/mm3 
30 If yes for Q. 28 Did receive ART  1. Yes 2. No 
31 If yes for Q.30 When did it start  ---/---/--- dd/mm/yy, ------ Duration on ART 
in month 
32 MDRTB Treatment regimen 1. cs-z-etho/pto-lfx-cm  
2. cs-z-PAS-lfx-cs  
3.other----------------------- 
33 Radiological finding 1. Cavity 2. Infiltration 3. Consolidation       
4. Efusion5. Hilar LAP 6. Fibrotic 
change 7. Other 
34 Baseline sputum smear grading 3+(>9 AFB/HPF) 
2+(1-9 AFB/HPF) 
1+(10-99AFB/100/HPF) 
Scanty (1-9 AFB/ HPF) 
Negative 
35 Final treatment outcome  1. Cured  
2.completed  
3.died  
4.LTF 
 5. transferred out 
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6. On treatment 
36 Symptoms at admission 1. Shortness of breath  
2. Fever 
3. Weight lose 
4. Hemoptysis 
5. Chest pain 
6. Sweating 
7. Fatigability 
8. Other  
 
Collected  
by____________________Signature ____________Date ________________ 
Supervised  
by___________________Signature ____________ Date _______________ 
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